Replies to post #1532 on GTC Biotherapeutics (fka GTCB)

[Lewis R Goudy]

Keitern here's another piece of the bull case
----------------------------------------------
...the federal debt has grown in dollar terms since 2001, it hasn't grown dramatically relative to the size of the economy.

But that's about to change, thanks to the country's three big entitlement programs - Social Security, Medicaid and especially Medicare. Medicaid and Medicare have grown progressively more expensive as the cost of health care has dramatically outpaced inflation over the past 30 years, a trend that is expected to continue for at least another decade or two.

And with the first baby boomers becoming eligible for Social Security in 2008 and for Medicare in 2011, the expenses of those two programs are about to increase dramatically due to demographic pressures. People are also living longer, which makes any program that provides benefits to retirees more expensive.

Medicare already costs four times as much as it did in 1970, measured as a percentage of the nation's gross domestic product. It currently comprises 13 percent of federal spending; by 2030, the Congressional Budget Office projects it will consume nearly a quarter of the budget...
-------------------------------------------------
http://apnews.myway.com/article/20061028/D8L1OC5G0.html
This shows the importance of a lower cost production platform
for therapeutics in the context of the political economy of the
US and over the time frame of long-term GTC investors.